These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11738551)

  • 1. Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens.
    Burow ME; Weldon CB; Tang Y; McLachlan JA; Beckman BS
    J Steroid Biochem Mol Biol; 2001 Nov; 78(5):409-18. PubMed ID: 11738551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage.
    Wilson JW; Wakeling AE; Morris ID; Hickman JA; Dive C
    Int J Cancer; 1995 May; 61(4):502-8. PubMed ID: 7759156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen treatment enhances the sensitivity of hormone-resistant breast cancer cells to doxorubicin.
    Scherbakov AM; Lobanova YS; Andreeva OE; Shatskaya VA; Krasil'nikov MA
    Biosci Rep; 2011 Apr; 31(2):137-43. PubMed ID: 20662767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.
    Teixeira C; Reed JC; Pratt MA
    Cancer Res; 1995 Sep; 55(17):3902-7. PubMed ID: 7641210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients.
    Santen R; Jeng MH; Wang JP; Song R; Masamura S; McPherson R; Santner S; Yue W; Shim WS
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):115-25. PubMed ID: 11850215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogens are pro-apoptotic in normal human breast epithelial cells.
    Somaï S; Chaouat M; Jacob D; Perrot JY; Rostène W; Forgez P; Gompel A
    Int J Cancer; 2003 Jul; 105(5):607-12. PubMed ID: 12740907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells.
    Smolnikar K; Löffek S; Schulz T; Michna H; Diel P
    Breast Cancer Res Treat; 2000 Oct; 63(3):249-59. PubMed ID: 11110059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.
    Sui M; Huang Y; Park BH; Davidson NE; Fan W
    Cancer Res; 2007 Jun; 67(11):5337-44. PubMed ID: 17545614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiestrogen ICI 182,780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completion.
    Cicatiello L; Addeo R; Altucci L; Belsito Petrizzi V; Boccia V; Cancemi M; Germano D; Pacilio C; Salzano S; Bresciani F; Weisz A
    Mol Cell Endocrinol; 2000 Jul; 165(1-2):199-209. PubMed ID: 10940498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
    Sui M; Jiang D; Hinsch C; Fan W
    Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo.
    Van Themsche C; Parent S; Leblanc V; Descôteaux C; Simard AM; Bérubé G; Asselin E
    Endocr Relat Cancer; 2009 Dec; 16(4):1185-95. PubMed ID: 19661132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling.
    Soulez M; Parker MG
    J Mol Endocrinol; 2001 Dec; 27(3):259-74. PubMed ID: 11719280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of estrogen receptor containing tumour cells to pure antiestrogens and the calmodulin inhibitor, calmidzolium chloride.
    Newton CJ; Eycott K; Green V; Atkin SL
    J Steroid Biochem Mol Biol; 2000 May; 73(1-2):29-38. PubMed ID: 10822022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
    DeFriend DJ; Anderson E; Bell J; Wilks DP; West CM; Mansel RE; Howell A
    Br J Cancer; 1994 Aug; 70(2):204-11. PubMed ID: 8054267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780.
    Lim KB; Ng CY; Ong CK; Ong CS; Tran E; Nguyen TT; Chan GM; Huynh H
    Breast Cancer Res Treat; 2001 Jul; 68(2):127-38. PubMed ID: 11688516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7.
    Leung LK; Wang TT
    Br J Cancer; 1999 Oct; 81(3):387-92. PubMed ID: 10507761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
    Chang J; Sui M; Fan W
    Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.